| scholarly article | Q13442814 |
| P50 | author | Xiaobo Zhou | Q89636879 |
| P2093 | author name string | Chih-Hao Lee | |
| Yan Bai | |||
| Gang Wang | |||
| Weiliang Qiu | |||
| Xingbin Ai | |||
| Zhiqiang Jiang | |||
| Nelson H Knudsen | |||
| Zun Zar Chi Naing | |||
| P2860 | cites work | Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function | Q24633262 |
| Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3. | Q38098825 | ||
| Moving beyond genetics: is FAM13A a major biological contributor in lung physiology and chronic lung diseases? | Q38243943 | ||
| Leptin modulates innate and adaptive immune cell recruitment after cigarette smoke exposure in mice | Q38343887 | ||
| Rejuvenating cellular respiration for optimizing respiratory function: targeting mitochondria. | Q38633001 | ||
| Genome-wide association study on the FEV1/FVC ratio in never-smokers identifies HHIP and FAM13A. | Q40587968 | ||
| Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression | Q40902162 | ||
| Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation | Q46220928 | ||
| β-Catenin regulates hepatic mitochondrial function and energy balance in mice | Q46551910 | ||
| Detrimental metabolic effects of combining long-term cigarette smoke exposure and high-fat diet in mice | Q46947704 | ||
| Serum leptin and skeletal differences between obese and non-obese patients with chronic obstructive pulmonary disease | Q47163438 | ||
| Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure | Q47271176 | ||
| Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants | Q81246791 | ||
| Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells | Q87434568 | ||
| Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids | Q87973835 | ||
| Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes | Q24645537 | ||
| The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications | Q27004651 | ||
| SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha} | Q28235481 | ||
| Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 | Q28237795 | ||
| Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice | Q28290039 | ||
| Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway | Q28510620 | ||
| Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha | Q28513388 | ||
| Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone | Q28579828 | ||
| Discovery and refinement of loci associated with lipid levels | Q28661470 | ||
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis | Q29416987 | ||
| Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. | Q30427183 | ||
| SIRT1 protects against cigarette smoke-induced lung oxidative stress via a FOXO3-dependent mechanism | Q33568637 | ||
| Variants in FAM13A are associated with chronic obstructive pulmonary disease | Q33687879 | ||
| Molecular mechanisms of fatty acid beta-oxidation enzyme catalysis | Q33858125 | ||
| A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. | Q34078111 | ||
| Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment | Q34099325 | ||
| Mitophagy-dependent necroptosis contributes to the pathogenesis of COPD | Q34117623 | ||
| Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema | Q34279364 | ||
| Deaths: final data for 2008. | Q34342648 | ||
| New genetic loci link adipose and insulin biology to body fat distribution | Q35114362 | ||
| Lipid Analysis of Airway Epithelial Cells for Studying Respiratory Diseases | Q35138292 | ||
| Cellular bioenergetics is regulated by PARP1 under resting conditions and during oxidative stress | Q35738810 | ||
| SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice | Q36005375 | ||
| Leptin, adiponectin and pulmonary diseases | Q36101219 | ||
| The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years | Q36101443 | ||
| Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes | Q36109296 | ||
| Pathogenesis of chronic obstructive pulmonary disease | Q36129048 | ||
| Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms | Q36207186 | ||
| Functional significance of apoptosis in chronic obstructive pulmonary disease | Q37008631 | ||
| A Chronic Obstructive Pulmonary Disease Susceptibility Gene, FAM13A, Regulates Protein Stability of β-Catenin | Q37213583 | ||
| An NT4/TrkB-dependent increase in innervation links early-life allergen exposure to persistent airway hyperreactivity | Q37503675 | ||
| An overview of beta-oxidation disorders. | Q37522964 | ||
| Mitochondria in lung diseases | Q37688339 | ||
| Lipid mediator profiling in pulmonary disease | Q37861811 | ||
| P433 | issue | 6 | |
| P921 | main subject | fatty acid | Q61476 |
| chronic obstructive pulmonary disease | Q199804 | ||
| P304 | page(s) | 738-748 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Genetic Control of Fatty Acid β-Oxidation in Chronic Obstructive Pulmonary Disease | |
| P478 | volume | 56 |
| Q52626684 | A functional SNP upstream of the ADRB2 gene is associated with COPD. |
| Q92661462 | An Updated Overview of Metabolomic Profile Changes in Chronic Obstructive Pulmonary Disease |
| Q90236813 | CPT1 regulates the proliferation of pulmonary artery smooth muscle cells through the AMPK-p53-p21 pathway in pulmonary arterial hypertension |
| Q93371877 | Cellular Metabolism in Lung Health and Disease |
| Q90289914 | Cigarette Smoke Reduces Fatty Acid Catabolism, Leading to Apoptosis in Lung Endothelial Cells: Implication for Pathogenesis of COPD |
| Q51760160 | Dealing with Stress: Defective Metabolic Adaptation in Chronic Obstructive Pulmonary Disease Pathogenesis. |
| Q57817674 | Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan |
| Q51246359 | FAM13A and POM121C are candidate genes for fasting insulin: functional follow-up analysis of a genome-wide association study. |
| Q48344753 | FAM13A, A Fatty Acid Oxidation Switch in Mitochondria. Friend or Foe in Chronic Obstructive Pulmonary Disease Pathogenesis? |
| Q55332454 | Genetic variants in FAM13A and IREB2 are associated with the susceptibility to COPD in a Chinese rural population: a case-control study. |
| Q88564826 | In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics |
| Q52642397 | Integrative genomics identifies new genes associated with severe COPD and emphysema. |
| Q64946809 | Lipid metabolism in chronic obstructive pulmonary disease. |
| Q49918024 | Metabolic reprogramming in the pathogenesis of chronic lung diseases including BPD, COPD, and pulmonary fibrosis. |
| Q93113555 | Mitochondrial biology in airway pathogenesis and the role of NRF2 |
| Q57289193 | Obesity-associated family with sequence similarity 13, member A (FAM13A) is dispensable for adipose development and insulin sensitivity |
| Q33838799 | The Roles of Reactive Oxygen Species and Nitric Oxide in Perfluorooctanoic Acid-Induced Developmental Cardiotoxicity and l-Carnitine Mediated Protection |
| Q51764891 | Trade-offs in aging lung diseases: a review on shared but opposite genetic risk variants in idiopathic pulmonary fibrosis, lung cancer and chronic obstructive pulmonary disease. |
| Q92643364 | Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation |
| Q64062154 | Weighted gene co-expression network analysis to explain the relationship between plasma total carotenoids and lipid profile |
| Q47801457 | What do polymorphisms tell us about the mechanisms of COPD? |
Search more.